To investigate whether canonical readouts of BMP and TGFβ signaling is altered in TIBD we performed Immunohistochemistry (IHC) on clinical samples containing bone with metastatic prostate cancer. This evidence concerns the gene TGFB1 and metastatic prostate carcinoma.